Copyright
©The Author(s) 2003.
World J Gastroenterol. Aug 15, 2003; 9(8): 1683-1688
Published online Aug 15, 2003. doi: 10.3748/wjg.v9.i8.1683
Published online Aug 15, 2003. doi: 10.3748/wjg.v9.i8.1683
Treatment (µm) | %Cell cycle distribution | %apoptosis | ||
G0/G1 | S | G2/M | ||
Control | 49.7 ± 1.5 | 34.8 ± 2.1 | 15.5 ± 1.1 | 2.1 ± 0.3 |
15d-PGJ2 | ||||
10 | 50.5 ± 2.6 | 34.2 ± 1.7 | 15.3 ± 0.5 | 13.9 ± 1.1b |
20 | 64.8 ± 2.9b | 19.5 ± 1.5b | 15.7 ± 0.2 | 33.5 ± 2.3b |
30 | 71.6 ± 4.2b | 14.1 ± 0.6b | 14.4 ± 1.3 | 55.8 ± 4.7b |
TGZ | ||||
10 | 54.2 ± 2.1 | 29.4 ± 1.3 | 16.6 ± 0.9 | 10.3 ± 1.1b |
20 | 61.5 ± 3.1b | 28.2 ± 1.7b | 14.9 ± 1.7 | 25.5 ± 1.8b |
30 | 68.9 ± 4.8b | 14.2 ± 0.8b | 16.9 ± 1.4 | 50.0 ± 4.1b |
- Citation: Li MY, Deng H, Zhao JM, Dai D, Tan XY. Peroxisome proliferator-activated receptor gamma ligands inhibit cell growth and induce apoptosis in human liver cancer BEL-7402 cells. World J Gastroenterol 2003; 9(8): 1683-1688
- URL: https://www.wjgnet.com/1007-9327/full/v9/i8/1683.htm
- DOI: https://dx.doi.org/10.3748/wjg.v9.i8.1683